↑ トップへ ← 戻る

 Drug(薬物リスト) ALL | DrugBank 

   e.g. "Sirolimus", "アダリムマブ"    Synonyms (Drugs) were also searched for.

A B C D E F G H  I  J K L M N O P Q R S T U V W X Y Z other

10 / 1,666 drugs found* Show info (disease name, etc.) on mouse-over.
 No.   DrugBank   薬物名(臨床試験情報から抽出)   KEGG DRUG  KEGG GENES  KEGG PATHWAY   指定難病告示番号
 1   Adalimumab  51件: Adalimumab; Adalimumab injection [humira]; Adalimumab (ada); Adalimumab (humira); Adalimumab (humira®); Adalimumab (up to 9 months exposure); Adalimumab 40 mg; Adalimumab 40 mg subcutaneous (sc) every other week (eow); Adalimumab 40mg q2w; Adalimumab 80 mg; Adalimumab pfs and pen; Adalimumab with methotrexate; Adalimumab-eu; Adalimumab-pfizer; Anti-tnf therapy (etanercept or adalimumab); Bdmard withdrawal (etanercept, adalimumab, infliximab, certolizumab, golimumab, tozilizumab, abatacept); Biosimilar product to adalimumab; Double-blind adalimumab; Etanercept or adalimumab; Humira (adalimumab); Humira 40mg solution for injection in pre-filled syringe (adalimumab); Humira® (adalimumab); Infliximab, etanercept, adalimumab; Methotrexate,adalimumab; New formulation adalimumab; Open-label adalimumab; Open-labeladalimumabrescue; Sb5 (proposed biosimilar to adalimumab); Tnf blockers (infliximab, adalimumab, etanercept); Tumor necrosis factor inhibitor (etanercept, infliximab, adalimumab, and golimumab); Adalimumab (40 mg); Adalimumab (d2e7); Adalimumab 40 mg eow or ew; Adalimumab and infliximab; Adalimumab injection; Adalimumab prn; Anti-tnf:adalimumab (subcutaneus); Application of adalimumab; Azathioprine or adalimumab and infliximab; Db adalimumab 40 mg eow; Db adalimumab 40 mg ew; Fitc-adalimumab; Infliximab and adalimumab; Infliximab or adalimumab or golimumab or vedolizumab or ustekinumab; Infliximab, adalimumab, certolizumab pegol; Ol adalimumab 40 mg; Start adalimumab in monotherapy; Treatment with adalimumab; Adalimumab 40 mg sc every other week; Adalimumab, etanercept, golimumab or infliximab; Gp2017 (adalimumab biosimilar);   D02597   1件: TNF   9件: Antigen processing and presentation, Apoptosis, Cytokine-cytokine receptor interaction, Inflammatory bowel disease (IBD), MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Osteoclast differentiation, Rheumatoid arthritis, TGF-beta signaling pathway   15件:
19,
37,
41,
46,
56,
84,
96,
97,
151,
160,
164,
222,
226,
269,
271
 2   Atorvastatin  9件: Atorvastatin; Interferon beta treatment to add-on atorvastatin treatment; Interferon beta-1b/atorvastatin group; Untreated to atorvastatin treatment; Atorvastatin tablet 20 mg; Atorvastatin 10mg; Atorvastatin 20mg; Lisinopril, losartan, and atorvastatin; Atorvastatin calcium;   D00258
 D00887
 D07474 
 1件: HMGCR   1件: Terpenoid backbone biosynthesis   17件:
13,
46,
49,
51,
58,
63,
79,
84,
88,
93,
96,
160,
222,
225,
265,
271,
299
 3   Bezafibrate  2件: Bezafibrate; Bezafibrate (drug);   D01366   1件: PPARA   2件: Adipocytokine signaling pathway, PPAR signaling pathway   5件:
20,
93,
94,
160,
316
 4   Cholesterol  9件: Cholesterol; Lysosomal acid lipase, esterase, cholesterol (human gene lipa), lysosomal acid lipase (human gene lipa); Recombinant human lysosomal acid lipase (rhlal), esterase, cholesterol (human gene lipa); Recombinant human lysosomal acid lipase (rhlal), esterase, cholesterol (human gene lipa), lysosomal acid lipase (human gene lipa); 3h-cholesterol bound to albumin; Cholesterol supplementation; Crystalline cholesterol oil-based suspension; Egg substitute, without cholesterol; Egg yolk preparation with cholesterol;   D00040   -   -   7件:
19,
90,
160,
259,
261,
301,
310
 5   Isotretinoin  1件: Isotretinoin;   D00348   1件: RARA   1件: Th17 cell differentiation   4件:
36,
39,
159,
160
 6   Lovastatin  5件: Lovastatin; Lovastatin 60 mg; Lovastatin ™; Lovastatin, then minocycline/lovastatin; Minocycline, then minocycline/lovastatin;   D00359   1件: HMGCR   1件: Terpenoid backbone biosynthesis   10件:
6,
34,
46,
79,
156,
160,
195,
206,
263,
310
 7   Oxiconazole  1件: Oxiconazole;   D00885
 D08313 
 -   -   1件:
160
 8   Pimecrolimus  2件: Pimecrolimus; Pimecrolimus 1% cream;   D05480   5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2   7件: Cellular senescence, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Osteoclast differentiation, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation   1件:
160
 9   Secukinumab  12件: Secukinumab; Secukinumab 150mg; Secukinumab 300mg; Secukinumab 300 mg, s.c.; Secukinumab (ain457); 150 mg double-blinded secukinumab; 150 mg open-label secukinumab; 300 mg double-blinded secukinumab; Ain457/secukinumab; Secukinumab (150 mg); Secukinumab (75 mg); Secukinumab 150 milligram [cosentyx];   D09967   1件: IL17A   2件: Cytokine-cytokine receptor interaction, Rheumatoid arthritis   7件:
13,
37,
41,
46,
160,
269,
271
 10   Zileuton  1件: Zileuton;   D00414   1件: ALOX5   1件: Arachidonic acid metabolism   3件:
85,
160,
164